ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.5 USD Market Closed
Market Cap: 433.6m USD

Wall Street
Price Targets

ADCT Price Targets Summary
ADC Therapeutics SA

Wall Street analysts forecast ADCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
44% Upside
Average
Price Target
8.16 USD
133% Upside
Highest
Price Target
10.5 USD
200% Upside
ADC Therapeutics SA Competitors:
Price Targets
6160
Beigene Ltd
39% Upside
CGON
CG Oncology Inc
82% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
66% Upside
6628
Transcenta Holding Limited
593% Upside
COV
Covalon Technologies Ltd
85% Upside
397030
AprilBio Co Ltd
14% Downside
9966
Alphamab Oncology
4% Upside
NBIX
Neurocrine Biosciences Inc
28% Upside

Revenue
Forecast

Revenue Estimate
ADC Therapeutics SA

For the last 6 years the compound annual growth rate for ADC Therapeutics SA's revenue is 100%. The projected CAGR for the next 4 years is 39%.

100%
Past Growth
39%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADCT's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

What is ADC Therapeutics SA's Revenue forecast?
Projected CAGR
39%

For the last 6 years the compound annual growth rate for ADC Therapeutics SA's revenue is 100%. The projected CAGR for the next 4 years is 39%.

Back to Top